Sign in to view content

Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID

Rishi P. Singh, MD

Video
Published 2019

Rishi P. Singh, MD

Diabetic Retinopathy Part I Symposium

Related

Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Andrew J. Barkmeier, MD
Updates from the Field
2024
Retinal Vascular Disease Take-Home Panel
Neil M. Bressler, MD
Annual Meeting Talks
2019
Cost of Initial Aflibercept, Laser, or Observation in Eyes With Diabetic Macular Edema and Good Vision Based on Management Approaches in Protocol V
Jennifer K. Sun, MD
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more